scispace - formally typeset
A

Anne Puel

Researcher at Rockefeller University

Publications -  273
Citations -  29510

Anne Puel is an academic researcher from Rockefeller University. The author has contributed to research in topics: Chronic mucocutaneous candidiasis & Medicine. The author has an hindex of 69, co-authored 232 publications receiving 23621 citations. Previous affiliations of Anne Puel include Curie Institute & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Paul Bastard, +140 more
- 23 Oct 2020 - 
TL;DR: A means by which individuals at highest risk of life-threatening COVID-19 can be identified is identified, and the hypothesis that neutralizing auto-Abs against type I IFNs may underlie critical CO VID-19 is tested.
Journal ArticleDOI

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, +172 more
- 23 Oct 2020 - 
TL;DR: The COVID Human Genetic Effort established to test the general hypothesis that life-threatening COVID-19 in some or most patients may be caused by monogenic inborn errors of immunity to SARS-CoV-2 with incomplete or complete penetrance finds an enrichment in variants predicted to be loss-of-function (pLOF), with a minor allele frequency <0.001.
Journal ArticleDOI

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.

TL;DR: CD14dim monocytes were weak phagocytes and did not produce ROS or cytokines in response to cell-surface Toll-like receptors, but selectively produced TNF-α, IL-1β, and CCL3 inresponse to viruses and immune complexes containing nucleic acids, via a proinflammatory TLR7-TLR 8-MyD88-MEK pathway.